These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Combined transplantation of skeletal myoblasts and bone marrow stem cells for myocardial repair in rats. Ott HC, Bonaros N, Marksteiner R, Wolf D, Margreiter E, Schachner T, Laufer G, Hering S. Eur J Cardiothorac Surg; 2004 Apr; 25(4):627-34. PubMed ID: 15037282 [Abstract] [Full Text] [Related]
23. Autologous skeletal myoblast transplantation improved hemodynamics and left ventricular function in chronic heart failure dogs. He KL, Yi GH, Sherman W, Zhou H, Zhang GP, Gu A, Kao R, Haimes HB, Harvey J, Roos E, White D, Taylor DA, Wang J, Burkhoff D. J Heart Lung Transplant; 2005 Nov; 24(11):1940-9. PubMed ID: 16297802 [Abstract] [Full Text] [Related]
24. Does the functional efficacy of skeletal myoblast transplantation extend to nonischemic cardiomyopathy? Pouly J, Hagège AA, Vilquin JT, Bissery A, Rouche A, Bruneval P, Duboc D, Desnos M, Fiszman M, Fromes Y, Menasché P. Circulation; 2004 Sep 21; 110(12):1626-31. PubMed ID: 15364802 [Abstract] [Full Text] [Related]
25. A comparison between percutaneous and surgical transplantation of autologous skeletal myoblasts in a swine model of chronic myocardial infarction. Gavira JJ, Perez-Ilzarbe M, Abizanda G, García-Rodríguez A, Orbe J, Páramo JA, Belzunce M, Rábago G, Barba J, Herreros J, Panizo A, de Jalón JA, Martínez-Caro D, Prósper F. Cardiovasc Res; 2006 Sep 01; 71(4):744-53. PubMed ID: 16843451 [Abstract] [Full Text] [Related]
26. Autologous myoblast transplantation for chronic ischemic mitral regurgitation. Messas E, Bel A, Morichetti MC, Carrion C, Handschumacher MD, Peyrard S, Vilquin JT, Desnos M, Bruneval P, Carpentier A, Menasché P, Levine RA, Hagège AA. J Am Coll Cardiol; 2006 May 16; 47(10):2086-93. PubMed ID: 16697329 [Abstract] [Full Text] [Related]
27. Mesothelial cell transplantation in the infarct scar induces neovascularization and improves heart function. Elmadbouh I, Chen Y, Louedec L, Silberman S, Pouzet B, Meilhac O, Michel JB. Cardiovasc Res; 2005 Nov 01; 68(2):307-17. PubMed ID: 15979058 [Abstract] [Full Text] [Related]
28. Cell transplantation: differential effects of myoblasts and mesenchymal stem cells. Guarita-Souza LC, Carvalho KA, Rebelatto C, Senegaglia A, Hansen P, Furuta M, Miyague N, Francisco JC, Olandoski M, Faria-Neto JR, Oliveira SA, Brofman PR. Int J Cardiol; 2006 Aug 28; 111(3):423-9. PubMed ID: 16290098 [Abstract] [Full Text] [Related]
29. Mesothelial cells vs. skeletal myoblasts for myocardial infarction. Bourahla B, Shafy A, Meilhac O, Elmadbouh I, Michel JB, Chachques JC. Asian Cardiovasc Thorac Ann; 2010 Feb 28; 18(2):153-60. PubMed ID: 20304850 [Abstract] [Full Text] [Related]
30. Skeletal myoblast sheet transplantation improves the diastolic function of a pressure-overloaded right heart. Hoashi T, Matsumiya G, Miyagawa S, Ichikawa H, Ueno T, Ono M, Saito A, Shimizu T, Okano T, Kawaguchi N, Matsuura N, Sawa Y. J Thorac Cardiovasc Surg; 2009 Aug 28; 138(2):460-7. PubMed ID: 19619796 [Abstract] [Full Text] [Related]
31. Repair of impaired myocardium by means of implantation of engineered autologous myoblast sheets. Memon IA, Sawa Y, Fukushima N, Matsumiya G, Miyagawa S, Taketani S, Sakakida SK, Kondoh H, Aleshin AN, Shimizu T, Okano T, Matsuda H. J Thorac Cardiovasc Surg; 2005 Nov 28; 130(5):1333-41. PubMed ID: 16256786 [Abstract] [Full Text] [Related]
35. Autologous skeletal myoblast transplantation for the treatment of postinfarction myocardial injury: phase I clinical study with 12 months of follow-up. Siminiak T, Kalawski R, Fiszer D, Jerzykowska O, Rzeźniczak J, Rozwadowska N, Kurpisz M. Am Heart J; 2004 Sep 28; 148(3):531-7. PubMed ID: 15389244 [Abstract] [Full Text] [Related]
36. Increasing transplanted cell survival with cell-based angiogenic gene therapy. Yau TM, Kim C, Ng D, Li G, Zhang Y, Weisel RD, Li RK. Ann Thorac Surg; 2005 Nov 28; 80(5):1779-86. PubMed ID: 16242455 [Abstract] [Full Text] [Related]
37. Skeletal myoblasts as a therapeutic agent. Menasché P. Prog Cardiovasc Dis; 2007 Nov 28; 50(1):7-17. PubMed ID: 17631434 [Abstract] [Full Text] [Related]
38. Angiogenic pretreatment to enhance myocardial function after cellular cardiomyoplasty with skeletal myoblasts. Retuerto MA, Beckmann JT, Carbray J, Patejunas G, Sarateanu S, Kane BJ, Smulevitz B, McPherson DD, Rosengart TK. J Thorac Cardiovasc Surg; 2007 Feb 28; 133(2):478-484.e2. PubMed ID: 17258586 [Abstract] [Full Text] [Related]
39. Comparison of the effects of fetal cardiomyocyte and skeletal myoblast transplantation on postinfarction left ventricular function. Scorsin M, Hagège A, Vilquin JT, Fiszman M, Marotte F, Samuel JL, Rappaport L, Schwartz K, Menasché P. J Thorac Cardiovasc Surg; 2000 Jun 28; 119(6):1169-75. PubMed ID: 10838534 [Abstract] [Full Text] [Related]
40. Hypoxia-inducible factor 1-alpha reduces infarction and attenuates progression of cardiac dysfunction after myocardial infarction in the mouse. Kido M, Du L, Sullivan CC, Li X, Deutsch R, Jamieson SW, Thistlethwaite PA. J Am Coll Cardiol; 2005 Dec 06; 46(11):2116-24. PubMed ID: 16325051 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]